Your browser doesn't support javascript.
Another Monoclonal Antibody Granted EUA to treat COVID-19.
Aschenbrenner, Diane S.
  • Aschenbrenner DS; Diane S. Aschenbrenner is a COVID-19 outbreak investigator for the Baltimore County Department of Health, Baltimore, MD. She also coordinates Drug Watch: daschenbrenner@baltimorecountymd.gov.
Am J Nurs ; 121(8): 22, 2021 08 01.
Article in English | MEDLINE | ID: covidwho-1612686
ABSTRACT
The Food and Drug Administration has granted emergency use authorization to sotrovimab for the treatment of mild to moderate COVID-19 in patients at increased risk for progression to severe illness.Sotrovimab is a monoclonal antibody that works directly against the spike protein of SARS-CoV-2 to block its attachment and entry into a human cell.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: United States Food and Drug Administration / Prior Authorization / Antibodies, Monoclonal Type of study: Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: Am J Nurs Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: United States Food and Drug Administration / Prior Authorization / Antibodies, Monoclonal Type of study: Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: Am J Nurs Year: 2021 Document Type: Article